Cme (CME) Gross Profit (2009 - 2026)

Cme (CME) has reported Gross Profit for 18 consecutive years, with $1.6 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Gross Profit changed 0.46% year-over-year to $1.6 billion in Q2 2026; TTM through Jun 2026 was $6.5 billion, a 5.42% increase from a year earlier, with the FY2025 full-year figure at $6.3 billion, up 6.99% from the prior year.
• Gross Profit was $1.6 billion for Q2 2026 at Cme, down from $1.8 billion in the prior quarter.
• Over five years, Gross Profit peaked at $1.8 billion in Q1 2026 and troughed at $1.1 billion in Q4 2022.
• A 5-year average of $1.4 billion and a median of $1.4 billion in 2024 frame the typical range for Gross Profit.
• Across the five-year window, Gross Profit climbed 20.18% in 2023 and dropped 2.6% in 2025, its largest moves.
• Over 5 years, Gross Profit stood at $1.1 billion in 2022, then advanced by 20.18% to $1.3 billion in 2023, then gained by 7.29% to $1.4 billion in 2024, then grew by 8.91% to $1.6 billion in 2025, then gained by 5.34% to $1.6 billion in 2026.
• The last three Gross Profit figures came in at $1.6 billion (Q2 2026), $1.8 billion (Q1 2026), and $1.6 billion (Q4 2025), per Business Quant data.